Related Experiment Video
Updated: Jan 30, 2026
11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.5K
Digital Health for Geriatric Oncology
Ramin Fallahzadeh1, Seyed Ali Rokni1, Hassan Ghasemzadeh1
1Ramin Fallahzadeh, Seyed Ali Rokni, and Hassan Ghasemzadeh, Washington State University, Pullman, WA; Enrique Soto-Perez-de-Celis, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; and Armin Shahrokni, Memorial Sloan Kettering Cancer Center, New York, NY.
JCO Clinical Cancer Informatics
|January 18, 2019
Summary
Digital health solutions show promise for monitoring older adults with cancer. Further research is needed to develop and test remote technologies for geriatric oncology symptom assessment and outcomes.
Area of Science:
- Geriatric Oncology
- Digital Health
- Remote Monitoring Technologies
Background:
- Geriatric oncology faces challenges in managing cancer in older adults.
- Digital health solutions offer potential for remote symptom monitoring.
- Existing remote health technologies are not adequately designed or tested for older cancer patients.
Purpose of the Study:
- To review state-of-the-art digital health solutions for geriatric oncology.
- To explore the application of emerging remote health-monitoring technologies in cancer care.
- To discuss benefits, motivations, limitations, and challenges of technology adoption for symptom monitoring in older adults with cancer.
Main Methods:
- Literature review of digital health solutions and remote health-monitoring technologies.
- Analysis of common symptoms and digital solutions for remote symptom assessment.
- Discussion of limitations and challenges for full-scale adoption in geriatric oncology.
Main Results:
- Rapid advances in Internet-of-things (IoT) technologies have led to numerous remote assessment systems.
- Few remote health solutions are specifically designed or tested for older cancer patients.
- A lack of consensus exists regarding the correlation between remote digital assessments and health outcomes in this population.
Conclusions:
- There is an unmet need for systems and clinical trials tailored to remote cancer management of older adults.
- Development of advanced remote technologies for symptom and psychological behavior monitoring is crucial.
- Collaborative studies involving computer scientists, oncologists, and patient advocates are key for future large-scale use of remote digital health in cancer research.
More Related Videos
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
269
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
269
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
235
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
235
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
259
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
259
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
253
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
253
01:21Health Literacy
5.4K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.4K